Pharmacoeconomic Evaluation of Tamsulosin Hydrochloride Sustained-release Capsules in the Treatment of Benign Prostatic Hyperplasia

Hengjin Dong,Ruwei Wang,Chunling Xu,Ling Wu
2015-01-01
Abstract:Objective To explore the effect of Tamsulosin Hydrochloride Sustained-release Capsules cost for the treatment of benign prostatic hyperplasia.Methods 6 September 2007 to October 2008 hospital 238 cases of benign prostate hyperplasia patient data colection,the patients were divided into treatment group and control group according to random number table method,119 cases in each,the control group of patients taking tamsulosin hydrochloride sustained-release capsules,treatment group patients taking tamsulosin hydrochloride sustained release capsules.The cost-effectiveness of the two groups of patients was compared.Results After treatment,IPSS score of two groups of patients were significantly lower than the treatment before andQmax were significantly higher than those before treatment,differences were statisticaly significant(P<0.05);the cost of the treatment group is lower than that of control group,and from the incremental cost-effectiveness ratio,if get an effect unit, the control group than in the treatment group spend more than 98 yuan.Conclusion Integrated efficacy of tamsulosin hydrochloride sustained release capsules and tamsulosin hydrochloride sustained release capsules in the treatment of benign prostatic hyperplasiais the same,but the cost of the former is low.
What problem does this paper attempt to address?